Composition of s(-) sodium ibuprofen

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 3119

Patent

active

056961650

ABSTRACT:
The use of S(-)sodium 2-(4-isobutylphenyl)propionate (the sodium salt of S(+)-ibuprofen) in pharmaceutical compositions for the treatment of inflammation, pain and pyrexia is described. Preferred compositions comprise S(-)sodium 2-(4-isobutylphenyl)propionate dihydrate. Processes to prepare S(-)sodium 2-(4-isobutyl-phenyl)propionate and its use in a process to prepare S(+) 2-(4-isobutylphenyl)propionic acid of high enantiomeric purity are also described.

REFERENCES:
patent: 4684666 (1987-08-01), Haas
patent: 4831147 (1989-05-01), Russell
patent: 4851444 (1989-07-01), Sunshine et al.
patent: 4859704 (1989-08-01), Haas
patent: 4861797 (1989-08-01), Haas
patent: 4865770 (1989-09-01), Piselli
patent: 4873231 (1989-10-01), Smith
patent: 4877620 (1989-10-01), Loew et al.
patent: 4931587 (1990-06-01), Piselli
patent: 4946997 (1990-08-01), Larsen et al.
patent: 4973745 (1990-11-01), Blaschke et al.
patent: 4980375 (1990-12-01), Sunshine et al.
patent: 4994604 (1991-02-01), Tung et al.
patent: 5015764 (1991-05-01), Manimaran
patent: 5100918 (1992-03-01), Sunshine et al.
patent: 5164398 (1992-11-01), Sims et al.
patent: 5189208 (1993-02-01), Stahly
patent: 5200558 (1993-04-01), Kwan
patent: 5220053 (1993-06-01), Choudhury et al.
patent: 5235095 (1993-08-01), Kadkhodayan et al.
patent: 5235100 (1993-08-01), Choudhury et al.
patent: 5235101 (1993-08-01), Patil et al.
patent: 5248213 (1993-09-01), Manimaran et al.
patent: 5248813 (1993-09-01), Manimaran et al.
patent: 5256816 (1993-10-01), Murray et al.
patent: 5260482 (1993-11-01), Pringle et al.
patent: 5278337 (1994-01-01), Manimaran et al.
patent: 5302751 (1994-04-01), Manimaran et al.
Kaiser et al, Journal of Pharmaceutical Sciences, vol. 65, No. 2, pp. 268-273, 1976.
Brooks et al, Journal of Chromatography, pp. 541-551, 1994.
Berge et al, Journal of Pharmaceutical Sciences, vol. 66, No. 1, pp. 1 and 2, 1977.
Goldstein et al., Jour. of Cardiovascular Pharmacology, 2:399-409 (1980).
Koopmann et al. Otolaryngology, pp. 558-559 (1981).
Esquivel et al., Thromb Haemostas, 48(1), pp. 87-90 (1982).
Colvin et al., Am. J. Hosp. Pharm., 1983, 40:1025-1026.
Stratton et al., Clin. Immunology & Immunopathology, 28, pp. 170-176, (1983).
Stratton et al., Gynecologic Oncology, 18, 145-159 (1984).
Manson et al., Circulation, 1985, 72, III-85, No. 338.
Walter et al. In vitro Cellular and Developmental Bioloty, vol. 22, No. 9, pp. 535-541 (1986).
Sordelli et al., Eur. J. Respir. Dis., 67, pp. 118-127 (1985).
Hubbard et al., Circulatory Shock, 26: 169-183 (1988).
Hubbard et al., Procs. Soc. Exp. Biol. Med., 181(1), 183 (1986).
Stewart et al., J. Trauma, 28(7), 1093 (1988).
Eller et al., Biopharmaceutics and Drug Disposition, vol. 10, pp. 269-278, (1989).
Parsons et al., Fasub. J., 3(4), No. 5452 (1989).
Johnston et al., Prostaglandins, Leukotrienes and Essential fatty Acids, 43, pp. 119-132 (1991).
Manimaran et al. "Optical Purification of Profen Drugs", Tetrahedron Assymetry, vol. 4, No. 8, pp. 1949-1954 (1993).
Jacques et al., Enantiomers, Racemates and Resolutions, Chapter 3, J. Wiley & Sons, NY, NY, pp. 167-213 (1981).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Composition of s(-) sodium ibuprofen does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Composition of s(-) sodium ibuprofen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition of s(-) sodium ibuprofen will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1608227

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.